Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment

被引：127
作者：
Brennan, ML
Hazen, SL
机构：
[1] Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
来源：
CURRENT OPINION IN LIPIDOLOGY | 2003年 / 14卷 / 04期
关键词：
myeloperoxidase; cardiovascular disease; inflammation; oxidation; nitric oxide;
D O I：
10.1097/00041433-200308000-00003
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The inflammatory protein myeloperoxidase is present, active and mechanistically poised to participate in the initiation and progression of cardiovascular disease. The many links between myeloperoxidase, oxidation and cardiovascular disease suggest this leukocyte protein may have clinical utility in risk stratification for cardiovascular disease status and outcomes.
引用
收藏
页码：353 / 359
页数：7
相关论文
共 54 条
  • [41] Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes
    Sugiyama, S
    Okada, Y
    Sukhova, GK
    Virmani, R
    Heinecke, JW
    Libby, P
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) : 879 - 891
  • [42] Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
    Takemoto, M
    Liao, JK
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (11) : 1712 - 1719
  • [43] Molecular action of vitamin E in lipoprotein oxidation: Implications for atherosclerosis
    Thomas, SR
    Stocker, R
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) : 1795 - 1805
  • [44] Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens - Production of the chemoattractant, 2-chlorohexadecanal
    Thukkani, AK
    Hsu, FF
    Crowley, JR
    Wysolmerski, RB
    Albert, CJ
    Ford, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) : 3842 - 3849
  • [45] Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis
    Upston, JM
    Niu, XW
    Brown, AJ
    Mashima, R
    Wang, HJ
    Senthilmohan, R
    Kettle, AJ
    Dean, RT
    Stocker, R
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (02) : 701 - 710
  • [46] Oxidized lipid accumulates in the presence of α-tocopherol in atherosclerosis
    Upston, JM
    Terentis, AC
    Morris, K
    Keaney, JF
    Stocker, R
    [J]. BIOCHEMICAL JOURNAL, 2002, 363 (03) : 753 - 760
  • [47] Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5
  • [48] VIOLI F, 2002, LANCET, V360, P7
  • [49] Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials
    Vivekananthan, DP
    Penn, MS
    Sapp, SK
    Hsu, A
    Topol, EJ
    [J]. LANCET, 2003, 361 (9374) : 2017 - 2023
  • [50] Cellular antioxidant effects of atorvastatin in vitro and in vivo
    Wassmann, S
    Laufs, U
    Müller, K
    Konkol, C
    Ahlbory, K
    Bäumer, AT
    Linz, W
    Böhm, M
    Nickenig, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (02) : 300 - 305
123456